2011
DR. ROMARIC LACROIX
Aix-Marseille University, France. For presentations delivered at the XXIII ISTH Congress in Kyoto, Japan, 2011
DR. TIM GANDERTON
Presentation at HAA2011 on his recently awarded Ph.D. topic, namely the “Mechanism of Lateral Self-Association of Von Willebrand Factor,” the data from which he recently published in the journal Blood.
PH.D. CANDIDATE BRAD McEWEN
Presentation at HAA2011, on the topic of “Low Dose Omega-3 on Fibrin and Thrombin Generation in Healthy Volunteers and Patients with Cardiovascular Disease.”
DR. VIVIEN CHEN
Oral presentations at HAA2012, including a detailed presentation on insights into thrombus initiation gained through intravital imaging.
DR. NEIL GOLDENBERG
Spoke at ISTH, and currently holds several clinical and academic positions, although in essence is a pediatric hematologist interested in pediatric hypercoagulability. Dr. Goldenberg has most recently developed a new global hemostasis assay (the clot formation and lysis assay, CloFAL).
DR. JOSEPH E. ITALIANO
Presentations at ISTH, including a talk in the Platelet Symposium in which he described the outstanding results of his work on megakaryocyte and the formation of platelets, as well as the role of platelets in angiogenesis.
2010
Dr. Adam Cuker (University of Pennsylvania)
Presentation at the 2010 American Society of Hematology meeting on immune thrombocytopenia (ITP), as well as his work related to a novel expert-based clinical scoring model for heparin-induced thrombocytopenia (HIT).
Dr. Jayandharan Giridhara Rao (Christian Medical College, Vellore, Tamil Nadu)
Papers on quality assurance in genetic testing for disorders of hemostasis, and the role of new technologies in hemophilia diagnosis and therapy at the Hemophilia World Congress in Argentina in 2010.
Dr. Timea Szanto (Helsinki University Central Hospital)
Presentation on platelet function and von Willebrand disease (VWD) at the Nordic Coagulation Meeting in 2010.
Dr. Birgitta Salmela (Helsinki University Central Hospital)
Paper on laboratory monitoring of new anticoagulants presented at the Nordic Coagulation Meeting in 2010.
Dr. Pia Riittaa-Maria Siljander (University of Helsinki)
Presentation on platelet-derived micro-particles given at the Nordic Coagulation Meeting in 2010.
2009
Dr. Salley Pels
 Dr. Salley Pels was nominated for her award as a result of an oral presentation she gave at the recent American Society for Hematology (ASH) 51st Annual Meeting held in December 2009, on the use of intravenous immune globulin in immune thrombocytopenia. Dr. Pels received her undergraduate degree in Chemistry at the Johns Hopkins University. She then went on to the University of Vermont College of Medicine for her Medical degree. Her training continued at Yale University and Yale-New Haven Children's Hospital, during a residency in General Pediatrics. Dr. Pels is currently nearing the end of a fellowship in Pediatric Hematology and Oncology at this facility. She has planned to complete an additional fellowship year in Clinical Hemostasis and Thrombosis, through a two-year award given by the National Hemophilia Foundation and Baxter.
Dr. Pels was granted several other awards in 2009, the Hemophilia and Thrombosis Research Society Young Investigators' Travel Award and the ASH Travel Award. Dr. Pels will prepare a paper on Immune Thrombocytopenia, the topic of her ASH presentation, for Seminars in Thrombosis and Hemostasis that is expected to appear in press sometime in 2011. We congratulate Dr. Pels on her award, look forward to her contribution to this journal and wish her the best of success for her future career.
Dr. Willem M. Lijfering
 Dr. Willem M. Lijfering was also nominated for his award as a result of an oral presentation he gave at the same meeting, the recent American Society for Hematology (ASH) 51st Annual Meeting held in December 2009. Dr. Lijfering's topic was on the risk of venous thrombosis as related to an increase in body mass index and as mediated by factor VIII induced activated protein C resistance. Dr. Lijfering was born in 1978 and was trained in Europe. Dr. Lijfering was awarded his MD in May 2004, and his first clinical experience was obtained in Australia where he worked as a resident medical officer at the Mount Isa Base Hospital.
From 2005 till 2009, he worked as an internist in training in the UMCG, Groningen, the Netherlands. He started a PhD in 2005, which was awarded in 2008, and began his training as a Clinical Epidemiologist in 2009. Dr. Lijfering has had a very successful career to date, and from 2006 onwards, has presented or supervised more than 24 communications to international congresses of which 11 were oral communications. He has managed to publish 11 articles over the past year, all related to venous thrombosis, including several in high impact journals such as Blood and Circulation. Willem Lijfering has a particular and long-term interest in arterial and venous thrombosis, and has agreed to prepare a paper on the topic of his ASH presentation for Seminars in Thrombosis and Hemostasis that is also expected to appear in press sometime in 2011. We congratulate Dr. Lijfering on his award, look forward to his contribution to this journal and wish him the best of success for his future career.
Learn more about the Eberhard F Mammen awards by selecting the following links:
|
